Flubrotizolam Blister – 10x 0.5mg

A. Introduction

Flubrotizolam Blister 10x 0.5mg is a premium laboratory-grade research chemical containing fluorobrominated thienotriazolodiazepine analog, designed for scientific institutions and analytical laboratories investigating high-potency benzodiazepine derivatives. This high-purity blister format provides researchers with consistent 0.5mg microdose units for ultra-trace method validation and forensic analysis in controlled settings.

B. Scientific Overview

Flubrotizolam belongs to the thienotriazolodiazepine class characterized by its fused thiophene-triazole-benzodiazepine scaffold with 2-fluoro and 8-bromo substitutions suitable for analytical profiling. In research contexts, it functions as an analytical reference for studying chromatographic behavior, mass spectrometry fragmentation patterns, and spectroscopic signatures of novel benzodiazepine analogs.

Laboratory investigations focus on its chemical properties including sub-microgram solubility profiles, thermal stability, and quantitative recovery under LC-MS/MS conditions, without reference to biological interactions.

C. Product Specifications

• Form: Blister-packed microdose tablets containing 0.5mg flubrotizolam per unit (10 tablets per blister)
• Label per unit: 0.5mg analytical portions in pharmaceutical-grade blister packaging
• Synonym: 2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f]triazolo[4,3-a]diazepine
• CAS Number: 1246791-67-3
• Molecular Formula: C₁₇H₁₂BrFN₄S
• Molecular Weight: 397.28 g/mol
• Purity: ≥98% (HPLC, typical batch purity)
• Storage Conditions: -20°C freezer, desiccated, protected from light/moisture for stability

D. Laboratory Use Context

Flubrotizolam Blister 10x 0.5mg is designated solely for in-vitro analytical research, including ultra-trace reference standard preparation, LC-HRMS method optimization at pg/mL levels, forensic toxicology screening for designer benzodiazepines, and impurity profiling in postmortem matrices.

Researchers utilize the microdose blister format for quantitative analysis across therapeutic/forensic ranges, positive ESI ionization studies ([M+H]+), and stability testing via UHPLC-QTOF protocols. All applications must comply with institutional laboratory safety standards.

E. Quality & Testing

Every batch receives comprehensive quality control:

• Certificate of Analysis (COA) with HPLC, LC-MS/MS, NMR identity confirmation and tablet uniformity testing
• Full batch traceability from synthesis through blister sealing and verification
• Third-party laboratory testing for purity, content uniformity (<2% RSD), dissolution profile, and residual solvents
• Manufactured under controlled conditions ensuring consistent microdose performance and extended stability

F. Shipping & Handling

Discreet worldwide shipping to verified research laboratories via secure, temperature-controlled carriers. Blister packaging meets IATA/DOT standards for Schedule I research chemicals with inherent moisture/light barrier protection. Full documentation provided for customs clearance; buyers confirm jurisdictional compliance prior to purchase.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product constitutes a controlled laboratory reagent supplied strictly for analytical research purposes. Not approved for human, veterinary, diagnostic, or therapeutic applications. No statements imply biological activity beyond controlled in-vitro analytical contexts.

Qualified researchers and institutions assume complete responsibility under local, federal, and international regulations. Seller disclaims all liability for non-research applications.